Transcriptional activation of HLA-DR alpha by interferon gamma requires a trans-acting protein.

AUTOR(ES)

Blanar, M A

RESUMO

Stimulation of the human epithelial-like cell line, HeLa, with interferon gamma (IFN-gamma) induces steady-state levels of HLA-DR alpha mRNA. Using a sensitive RNase-mapping procedure, we detect induced HLA-DR alpha mRNA as early as 8 hr after IFN-gamma treatment; maximal accumulation occurs by 48 hr. Treatment with the protein synthesis inhibitor, cycloheximide, abolishes the IFN-gamma-induced accumulation of HLA-DR alpha mRNA, indicating that de novo synthesis of a trans-acting protein factor is required for induction of this major histocompatibility complex class II gene. Nuclear run-off transcription assays revealed that IFN-gamma acts by directly stimulating the transcription rate of HLA-DR alpha. Similarly, IFN-gamma increased the transcription rate of the class I HLA-A2-encoding gene as well as that of the human invariant chain gene. IFN-gamma-induced transcription of HLA-DR alpha and of the invariant chain gene was blocked by treatment with cycloheximide, but IFN-gamma-induced transcription of HLA-A2 was unaffected. Our findings show that transcriptional induction of HLA-DR alpha and the invariant chain gene by IFN-gamma requires the action of an unidentified trans-acting protein.

Documentos Relacionados

• Gene induction by interferons: functional complementation between trans-acting factors induced by alpha interferon and gamma interferon.
• B-cell-specific and interferon-gamma-inducible regulation of the HLA-DR alpha gene.
• Trans-activation of HLA-DR gene by hepatitis B virus X gene product.
• Transcriptional regulation by triiodothyronine requires synergistic action of the thyroid receptor with another trans-acting factor.
• DNA methylation and expression of HLA-DR alpha.